Literature DB >> 19922526

Normoxic destabilization of ATF-4 depends on proteasomal degradation.

M Wottawa1, J Köditz, D M Katschinski.   

Abstract

AIM: Hypoxia-inducible gene expression is an important physiological adaptive mechanism in response to a decreased oxygen supply. We have recently described an oxygen- and prolyl-4-hydroxylase (PHD)3-dependent stabilization of the activating transcription factor 4 (ATF-4). The aim of the present study was to examine if the normoxic destabilization of ATF-4 is regulated by oxygen-dependent proteasomal degradation.
METHODS: We determined poly-ubiquitination of ATF-4 in normoxia compared to hypoxia by immunoprecipitation and immunoblots. Furthermore, we analysed the expression of the ATF-4 target gene GADD153 as a function of oxygen concentration.
RESULTS: ATF-4 protein levels were not detectable in normoxia. Normoxic degradation correlated with an oxygen-dependent poly-ubiquitination of ATF-4, which was hindered by hypoxic incubation of the cells. As a result of hypoxia, GADD153 was expressed. The hypoxic GADD153 expression was attenuated or increased by transfecting the cells with ATF-4 siRNA or PHD3 siRNA respectively.
CONCLUSION: Our results demonstrate the involvement of oxygen-dependent proteasomal degradation of ATF-4 in the hypoxia-induced expression of GADD153. Taken together, hypoxia/PHD3-regulated stabilization of ATF-4 by hindering oxygen-dependent degradation may play a critical role in linking cell fate decisions to oxygen availability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922526     DOI: 10.1111/j.1748-1716.2009.02060.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  4 in total

Review 1.  The 26S proteasome complex: an attractive target for cancer therapy.

Authors:  Sarah Frankland-Searby; Sukesh R Bhaumik
Journal:  Biochim Biophys Acta       Date:  2011-10-18

2.  Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions.

Authors:  Lija Swain; Marieke Wottawa; Annette Hillemann; Angelika Beneke; Haruki Odagiri; Kazutoyo Terada; Motoyoshi Endo; Yuichi Oike; Katja Farhat; Dörthe M Katschinski
Journal:  J Leukoc Biol       Date:  2014-03-13       Impact factor: 4.962

3.  FIH Regulates Cellular Metabolism through Hydroxylation of the Deubiquitinase OTUB1.

Authors:  Carsten C Scholz; Javier Rodriguez; Christina Pickel; Stephen Burr; Jacqueline-Alba Fabrizio; Karen A Nolan; Patrick Spielmann; Miguel A S Cavadas; Bianca Crifo; Doug N Halligan; James A Nathan; Daniel J Peet; Roland H Wenger; Alex Von Kriegsheim; Eoin P Cummins; Cormac T Taylor
Journal:  PLoS Biol       Date:  2016-01-11       Impact factor: 8.029

Review 4.  HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.

Authors:  Andrey A Poloznikov; Stepan A Nersisyan; Dmitry M Hushpulian; Eliot H Kazakov; Alexander G Tonevitsky; Sergey V Kazakov; Valery I Vechorko; Sergey V Nikulin; Julia A Makarova; Irina G Gazaryan
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.